Company Overview of Carolus Therapeutics, Inc.
Carolus Therapeutics, Inc., a development-stage biopharmaceutical company, develops drugs for the treatment of acute and chronic inflammatory diseases in the United States. The company focuses on therapeutic strategies to noninvasively monitor and disrupt proinflammatory interactions of chemokines, and prevent or reverse inflammation associated with an array of human diseases, including atherosclerosis, rheumatoid arthritis, multiple sclerosis, sepsis, organ transplantation, and cancer. Carolus Therapeutics, Inc. was incorporated in 2007 and is based in San Diego, California.
5626 Oberlin Drive
San Diego, CA 92121
Founded in 2007
Key Executives for Carolus Therapeutics, Inc.
Carolus Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Epicrop Technologies Inc.||United States|
|Kinex Pharmaceuticals, Inc.||United States|
|Epigenomics, Inc.||United States|
|CrossCoat Medical, LLC||United States|
|Abraxis BioScience, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Carolus Therapeutics, Inc., please visit www.carolustherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.